DN

Dr. Upendra Nagaich

Also known as: Nagaich U., U. Nagaich

Jiwaji University, Acharya and BM Reddy College of Pharmacy

ORCID iD 0000-0003-0076-6885
Follow

About

A visionary leader, pioneering pharmaceutical scientist, and serial entrepreneur with over two decades of transformative impact across research, education, market intelligence, and industry consulting. Dr. Nagaich founded SPER Market Research in 2015, building it into a globally recognized intelligence and consulting enterprise operating across 50+ countries and 20+ industries.

As Editor-in-Chief of JAPTR (Q2, Wolters Kluwer–Medknow), National Secretary of SPER India, and currently Adjunct Professor at Dr. D. Y. Patil Medical College, Hospital and Research Centre, DPU, Pimpri, Pune, India and was Distinguished Honorary Professor at Saveetha University, Chennai he bridges the worlds of science, business, and academia with strategic depth.

Recognized among Stanford University's Top 2% of Scientists Worldwide (2025 & 2023) and listed among the 100 Most Impactful Healthcare Leaders globally.

Seasoned Founder & CEO with 20+ years focused on consulting and market intelligence for pharma, biotech, medtech, and healthcare systems. Expert at turning complex clinical and commercial questions into actionable market strategies, competitive intelligence, and launch ready evidence that de risk product decisions and accelerate commercial adoption. Proven in building advisory practices, securing enterprise engagements, and delivering measurable client impact across 30+ markets.

Dr. Nagaich lead a consulting and market intelligence practice that helps pharma, biotech, medtech, and payer organisations make smarter commercial decisions. His teams deliver primary and secondary market research, competitive landscaping, payer/provider insights, KOL advisory programs, pricing and access modelling, and launch readiness support. We combine rigorous methodology with practical commercial judgement to produce clear recommendations, go to market plans, and evidence packages that drive faster uptake and better outcomes.

Core strengths include enterprise client engagement, bespoke research design, vendor governance, delivery assurance, and executive advisory. Typical engagements include product value proposition testing, target market sizing, KOL network design, and commercial due diligence for licensing or investment decisions.

Selected achievements

• Client impact: Led consulting engagements that informed pricing, positioning, and launch strategy for multiple products that entered 10+ markets.
• Enterprise relationships: Secured long term contracts with multinational pharma clients and health systems, representing repeat revenue and strategic partnerships.
• Market coverage: Managed multi market intelligence projects spanning NA, APAC, EMEA, and LATAM.
• Thought leadership: Speaker and contributor on market access, evidence strategy, and competitive intelligence for industry forums.
• Authored more than 160 influential publications in reputed scientific journals, filed 13 patents.

Board, advisory and industry contributions

• Advisory board member to healthcare start ups and portfolio teams advising on market entry and commercial strategy.
• National Secretary, Society of Pharmaceutical Education & Research India - contributing to industry academia linkages in market intelligence.

Recipient of many prestigious awards:

• Top Transformational Leaders to follow in 2024
• Global Business Leader of the Year Award
• 100 Most Impactful Healthcare Leaders

Employment

Employment history is unavailable.

Education

  • Jiwaji University B.Pharm.
  • Acharya and BM Reddy College of Pharmacy M.Pharm.
  • Jiwaji University Ph.D.

Projects & Funding

Projects & funding information is unavailable.

Publications (149)